Richard Koo - Amphastar Independent Director
| AMPH Stock | USD 42.08 0.83 2.01% |
Director
Mr. Richard Koo, CPA is Independent Director of the Company. He has served as a member of our board of directors since August 2003 and also served as a member of our board of directors from January 1997 to February 2002. Mr. Koo was the managing partner of Koo, Chow and Company, Certified Public Accountants since 1979, CEO and President of K.C. Group International Inc. since February 2003 and a previously served as director of EverTrust Bank from January 2009 until 2017. Prior to Koo, Chow and Company, Mr. Koo worked with PricewaterhouseCoopers LLP in various public offering audit assignments. Mr. Koo has worked as a finance and taxation expert for the United Nations since 2002.
| Age | 77 |
| Tenure | 22 years |
| Professional Marks | MBA |
| Address | 11570 6th Street, Rancho Cucamonga, CA, United States, 91730 |
| Phone | 909 980 9484 |
| Web | https://www.amphastar.com |
Amphastar Management Efficiency
The company has return on total asset (ROA) of 0.1107 % which means that it generated a profit of $0.1107 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2355 %, meaning that it created $0.2355 on every $100 dollars invested by stockholders. Amphastar's management efficiency ratios could be used to measure how well Amphastar manages its routine affairs as well as how well it operates its assets and liabilities. The Amphastar's current Return On Tangible Assets is estimated to increase to 0.16. The Amphastar's current Return On Capital Employed is estimated to increase to 0.16. As of now, Amphastar's Intangible Assets are increasing as compared to previous years. The Amphastar's current Return On Tangible Assets is estimated to increase to 0.16, while Other Assets are projected to decrease to under 35.9 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Kristine Romine | Evolus Inc | 53 | |
| Andreas Wicki | Pacira Pharmaceuticals | 59 | |
| Patrick Walsh | ANI Pharmaceuticals | 57 | |
| Paul Mitchell | Alkermes Plc | 64 | |
| Floyd Bloom | Alkermes Plc | 80 | |
| Meredith Kaya | Ironwood Pharmaceuticals | N/A | |
| Amy Schulman | Ironwood Pharmaceuticals | 57 | |
| Dawn Zier | Prestige Brand Holdings | 55 | |
| Norah Barlow | Evotec SE ADR | N/A | |
| Frederick Hudson | Supernus Pharmaceuticals | 72 | |
| Gerald Carlson | Phibro Animal Health | 75 | |
| Liam Ratcliffe | Deciphera Pharmaceuticals LLC | 53 | |
| Dennis Walsh | Deciphera Pharmaceuticals LLC | 50 | |
| George Conrades | Ironwood Pharmaceuticals | 76 | |
| David Nash | ANI Pharmaceuticals | 62 | |
| Edward Benz | Deciphera Pharmaceuticals LLC | 71 | |
| Wendy Dixon | Alkermes Plc | 62 | |
| John Siebert | Supernus Pharmaceuticals | 78 | |
| Bosun Hau | Evolus Inc | 39 | |
| Robert Breyer | Alkermes Plc | 73 | |
| Gary Lyons | Neurocrine Biosciences | 66 | |
Management Performance
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.11 |
Amphastar P Leadership Team
Elected by the shareholders, the Amphastar's board of directors comprises two types of representatives: Amphastar inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amphastar. The board's role is to monitor Amphastar's management team and ensure that shareholders' interests are well served. Amphastar's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amphastar's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Shohet, Independent Director | ||
| Ziping Luo, Chief Chairman | ||
| Peter Langosh, VP Audit | ||
| Richard Koo, Independent Director | ||
| Marilyn Purchase, Corporate Executive VP of Operations and President of International Medication Systems Ltd | ||
| Michael Zasloff, Independent Director | ||
| Jason Shandell, President Director | ||
| Jacob MBA, Marketing Sales | ||
| William Peters, CFO, Sr. VP and Treasurer | ||
| Floyd Petersen, Independent Director | ||
| Jacob Liawatidewi, Senior Vice President of Sales and Marketing, Corporate Administration Center, Corporate Secretary | ||
| Rong Zhou, Executive Vice President - Production Center and President of Armstrong Pharmaceuticals, Inc. | ||
| MP MBA, Senior Operations | ||
| Richard Prins, Independent Director | ||
| William MBA, Executive CFO | ||
| Rong MS, Senior Production | ||
| Dan MBA, Vice Communication | ||
| Mary Luo, Chairman, Chief Scientist and COO | ||
| Howard Lee, Independent Director | ||
| Yongfeng Zhang, President, CoFounder | ||
| Jack Zhang, CEO, Chief Science Officer and Director | ||
| Diane Gerst, President Amphastar Nanjing Pharmaceuticals Co., Ltd |
Amphastar Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amphastar a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 2.35 B | ||||
| Shares Outstanding | 48.87 M | ||||
| Shares Owned By Insiders | 22.02 % | ||||
| Shares Owned By Institutions | 70.57 % | ||||
| Number Of Shares Shorted | 3.87 M | ||||
| Price To Earning | 972.67 X |
Pair Trading with Amphastar
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amphastar position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amphastar will appreciate offsetting losses from the drop in the long position's value.Moving together with Amphastar Stock
| 0.61 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Amphastar Stock
| 0.8 | MPW | Medical Properties Trust Aggressive Push | PairCorr |
| 0.74 | GCTK | GlucoTrack | PairCorr |
| 0.73 | AEZS | Aeterna Zentaris Financial Report 14th of May 2024 | PairCorr |
| 0.59 | LMAT | LeMaitre Vascular Financial Report 7th of May 2024 | PairCorr |
| 0.56 | DXR | Daxor | PairCorr |
The ability to find closely correlated positions to Amphastar could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amphastar when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amphastar - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amphastar P to buy it.
The correlation of Amphastar is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amphastar moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amphastar P moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amphastar can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amphastar P. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Amphastar's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.055 | Earnings Share 2.6 | Revenue Per Share 13.351 | Quarterly Revenue Growth 0.319 | Return On Assets 0.1107 |
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.